Literature DB >> 11576783

Evaluation of the mechanical destructive force in the stomach of dog.

M Kamba1, Y Seta, A Kusai, K Nishimura.   

Abstract

Orally administered dosage forms receive a destructive force in the gastrointestinal (GI) tract due to peristalsis. In this study, the destructive force was measured with a 'destructive force-dependent release system' (DDRS). DDRS is a press-coated tablet with an extremely brittle outer layer composed of highly hydrophobic Teflon(R) powder, which is molded with a weak compression force. Teflon(R) powder forms a porous but water-impermeable layer around the core tablet. A marker drug contained in the core tablet is released only when the tablet receives a force larger than its pre-determined crushing strength. A comparison of the physiological conditions in the GI tract of dogs with those of humans, including the destructive force against tablets in the stomach, helps us to understand their difference in bioavailability of oral dosage forms. With DDRS, it is possible to evaluate the destructive force of both human and dog stomach using the same method. Therefore, the destructive force data from human and dog can be directly compared. The destructive force in the dog stomach was evaluated to be 3.2 N, which was considerably stronger than that of humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576783     DOI: 10.1016/s0378-5173(01)00844-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics.

Authors:  Marilyn N Martinez; Jonathan P Mochel; Sibylle Neuhoff; Devendra Pade
Journal:  AAPS J       Date:  2021-04-27       Impact factor: 4.009

2.  Controlled porosity solubility modulated osmotic pump tablets of gliclazide.

Authors:  Arti Banerjee; P R P Verma; Subhash Gore
Journal:  AAPS PharmSciTech       Date:  2014-11-07       Impact factor: 3.246

3.  Understanding gastric forces calculated from high-resolution pill tracking.

Authors:  Bryan Laulicht; Anubhav Tripathi; Vincent Schlageter; Pavel Kucera; Edith Mathiowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

4.  In vivo performance of an oral MR matrix tablet formulation in the beagle dog in the fed and fasted state: assessment of mechanical weakness.

Authors:  Fiona McInnes; Nicola Clear; Michael Humphrey; Howard N E Stevens
Journal:  Pharm Res       Date:  2007-10-05       Impact factor: 4.200

5.  Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination.

Authors:  Rajagopal Kumaravelrajan; Nallaperumal Narayanan; Venkatesan Suba
Journal:  Lipids Health Dis       Date:  2011-04-11       Impact factor: 3.876

6.  Development of Paroxetine Hydrochloride Single Layer Controlled-Release Tablets Based on 3² Factorial Design.

Authors:  Yao Yang; Zhengwei Huang; Xuan Zhang; Jinyuan Li; Ying Huang; Wanxin Chen; Xin Pan; Chuanbin Wu
Journal:  Pharmaceutics       Date:  2018-11-20       Impact factor: 6.321

7.  IVIVC for Extended Release Hydrophilic Matrix Tablets in Consideration of Biorelevant Mechanical Stress.

Authors:  Valentyn Mohylyuk; Seyedreza Goldoozian; Gavin P Andrews; Andriy Dashevskiy
Journal:  Pharm Res       Date:  2020-10-22       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.